Sun: Teva, Mellanox drag market down

Dual listed technology companies including Teva, Perrigo and Mellanox led the TASE down today but EZchip bucked the market.

The Tel Aviv Stock Exchange (TASE) fell today. The Tel Aviv 25 Index fell 0.93% to 1,219.46 points, the Tel Aviv 100 Index fell 1.08% to 1,071.17 points, and the TechBlue 50 Index fell 1.59% to 326.29 points. Turnover was NIS 992 million.

The TASE fell sharply today, despite a mixed session on European markets but in line with losses on Wall Street on Friday.

In the foreign currency market, options pointed to a 0.12% drop in the shekel-dollar exchange rate, compared with Friday's representative rate, to NIS 3.794/$, and no change in the shekel-euro exchange rate at NIS 4.97/€.

In the bond market, both long-term Shahar unlinked shekel government bonds fell by up to 0.1%, but long term Galil CPI-linked government bonds rose by up to 0.1%. The corporate bond benchmark Tel-Bond 20 Index fell 0.05%.

In the stock market, dual listed technology firms led the losses with Mellanox falling a further 6.2%, the largest fall on the Tel Aviv 25 Index. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) fell a further 3.8%, after publishing its strategic program last week, on the day's largest trading volume of NIS 85 million. Teva successfully raised $2 billion in debt on Friday in an offering of two bond series by subsidiaries. Between them Teva and Mellanox represent 15% of trading on the Tel Aviv 25 Index.

Another dual-listed companies that also had a bad day was Perrigo Company (Nasdaq:PRGO; TASE:PRGO), which fell 3%. But EZchip Semiconductor Ltd. (Nasdaq: EZCH; TASE:EZCH) rose 3.7%.

Outside the Tel Aviv 25, online translation company Babylon Ltd. (TASE:BBYL) fell 9.2% and Allot Communications Ltd. (Nasdaq:ALLT; TASE: ALLT) was down 12.1%, while the Technology Index fell 2%.

The Banking Index fell 0.2% with Bank Leumi (TASE: LUMI) up 1.2% and Bank Hapoalim (TASE: POLI) down 0.8%.

IDB Holding Corp. Ltd. (TASE:IDBH) fell 5.7% and its bonds were down 6.1% on news that the company is suspending new philanthropic initiatives.

Aposense Ltd. (TASE: APOS) fell 48.3% after reporting unsatisfactory results in a clinical trial.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018